Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Hüsing-Kabar

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Deutsche Medizinische Wochenschrift (1946)|October 9, 2019
[Current approaches for treatment of hereditary transthyretin amyloidosis (ATTR)]Andree Zibert, Anna Hüsing-Kabar, Hartmut Schmidt
Nutrients|May 28, 2022
Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 PatientsRichard Vollenberg, Phil-Robin Tepasse, Manfred Fobker, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 15, 2021
[Chronic intestinal failure]Jens G Brockmann, Anna Hüsing-Kabar, Katharina Bohlen, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 13, 2020
Regression of cardiac amyloid load documented by cardiovascular magnetic resonance in a patient with hereditary amyloidosisAnca Florian, Michael Bietenbeck, Grigorios Chatzantonis, et al.
European Heart Journal. Case Reports|November 24, 2021
Genome silencer therapy leading to 'regression' of cardiac amyloid load on cardiovascular magnetic resonance: a case reportAnca Florian, Michael Bietenbeck, Anna Hüsing-Kabar, et al.
Canadian Journal of Gastroenterology & Hepatology|August 30, 2018
Portal Hypertensive Polyposis in Advanced Liver Cirrhosis: The Unknown Entity?David Kara, Anna Hüsing-Kabar, Hartmut Schmidt, et al.
Orphanet Journal of Rare Diseases|October 15, 2020
Patient-reported outcomes on familial amyloid polyneuropathy (FAP)Fabian J Bolte, Christel Langenstroer, Frauke Friebel, et al.
The Journal of International Medical Research|July 13, 2018
Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failureNurettin Dogan, Anna Hüsing-Kabar, Hartmut H Schmidt, et al.
United European Gastroenterology Journal|March 28, 2020
Serum levels of ferritin and transferrin serve as prognostic factors for mortality and survival in patients with end-stage liver disease: A propensity score-matched cohort studyJörn Arne Meier, Arne Bokemeyer, Friederike Cordes, et al.
Annals of Transplantation|September 29, 2018
Pictorial Representation of Illness and Self Measure (PRISM): A Novel Visual Instrument to Quantify Suffering in Liver Cirrhosis Patients and Liver Transplant RecipientsIyad Kabar, Anna Hüsing-Kabar, Miriam Maschmeier, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Deutsche Medizinische Wochenschrift (1946)|October 9, 2019
[Current approaches for treatment of hereditary transthyretin amyloidosis (ATTR)]Andree Zibert, Anna Hüsing-Kabar, Hartmut Schmidt
Nutrients|May 28, 2022
Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 PatientsRichard Vollenberg, Phil-Robin Tepasse, Manfred Fobker, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 15, 2021
[Chronic intestinal failure]Jens G Brockmann, Anna Hüsing-Kabar, Katharina Bohlen, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 13, 2020
Regression of cardiac amyloid load documented by cardiovascular magnetic resonance in a patient with hereditary amyloidosisAnca Florian, Michael Bietenbeck, Grigorios Chatzantonis, et al.
European Heart Journal. Case Reports|November 24, 2021
Genome silencer therapy leading to 'regression' of cardiac amyloid load on cardiovascular magnetic resonance: a case reportAnca Florian, Michael Bietenbeck, Anna Hüsing-Kabar, et al.
Canadian Journal of Gastroenterology & Hepatology|August 30, 2018
Portal Hypertensive Polyposis in Advanced Liver Cirrhosis: The Unknown Entity?David Kara, Anna Hüsing-Kabar, Hartmut Schmidt, et al.
Orphanet Journal of Rare Diseases|October 15, 2020
Patient-reported outcomes on familial amyloid polyneuropathy (FAP)Fabian J Bolte, Christel Langenstroer, Frauke Friebel, et al.
The Journal of International Medical Research|July 13, 2018
Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failureNurettin Dogan, Anna Hüsing-Kabar, Hartmut H Schmidt, et al.
United European Gastroenterology Journal|March 28, 2020
Serum levels of ferritin and transferrin serve as prognostic factors for mortality and survival in patients with end-stage liver disease: A propensity score-matched cohort studyJörn Arne Meier, Arne Bokemeyer, Friederike Cordes, et al.
Annals of Transplantation|September 29, 2018
Pictorial Representation of Illness and Self Measure (PRISM): A Novel Visual Instrument to Quantify Suffering in Liver Cirrhosis Patients and Liver Transplant RecipientsIyad Kabar, Anna Hüsing-Kabar, Miriam Maschmeier, et al.
Pageof 3